InstalabLoading...
InstalabLoading...
Your body does not make sterigmatocystin. It is a poison produced by molds, and if it shows up in your urine, it means you have been exposed, most likely through contaminated food or a moldy indoor environment. The International Agency for Research on Cancer classifies it as a possible human carcinogen (Group 2B), placing it in the same concern category as some pesticides and industrial chemicals.
This is not a routine lab marker with established clinical thresholds. It is an exploratory exposure test, useful for people investigating whether mold is affecting their health or for anyone who wants to know whether fungal toxins are making it into their body. A single reading tells you about recent exposure. Tracking over time, especially after changes to diet or living environment, tells you whether those changes are working.
Sterigmatocystin is a mycotoxin, a toxic chemical made by certain species of Aspergillus mold, especially Aspergillus versicolor and Aspergillus nidulans. Chemically, it sits one step before aflatoxin B1 in the same production chain inside the mold. Aflatoxin B1 is one of the most potent liver carcinogens known, and sterigmatocystin shares much of its structure and toxic behavior.
When you eat contaminated food or breathe contaminated dust, sterigmatocystin enters your body, gets partially broken down by your liver (including conversion to a form called a glucuronide conjugate, where the body attaches a sugar molecule to the toxin for easier elimination), and is eventually excreted in urine. That urine measurement is what this test captures. It reflects recent dietary or environmental exposure to toxin-producing molds, not any internal disease process.
Sterigmatocystin has been found in a wide range of foods: grains, corn, bread, cheese, coffee, spices, nuts, and fermented products. It also appears in animal feeds and indoor dust from damp buildings. In most cases, it shows up alongside other mycotoxins rather than alone, which means a positive result may signal broader mold contamination in your diet or surroundings.
A study of 492 Spanish adults found that mycotoxin exposure was common, with dietary factors like cereal and meat consumption predicting higher levels of several emerging mycotoxins. A separate study measuring sterigmatocystin in plasma (blood, not urine) from 438 adults in northern Spain detected the toxin in about 86% of samples after a lab step that released sterigmatocystin from its inactive conjugated forms, suggesting that low-level exposure is widespread even in European populations with relatively clean food supplies.
The health concern around sterigmatocystin comes primarily from animal and laboratory cell studies, not from large human outcome trials. That distinction matters. The toxin has been shown to damage liver and kidney cells, cause DNA damage by forming chemical bonds with DNA strands (called DNA adducts), trigger cell death, and disrupt immune function in animal and cell models. These findings are the basis for its classification as a possible human carcinogen.
In humans, the picture is less clear. No large studies have directly linked urinary sterigmatocystin levels to specific diseases. However, the close chemical relationship between sterigmatocystin and aflatoxin B1, which does have strong human carcinogenicity data for liver cancer, is the primary reason researchers treat sterigmatocystin exposure as a genuine health concern rather than a theoretical one.
Sterigmatocystin is not only a food contaminant. A study of 462 students in Malaysian schools measured mycotoxins in classroom dust and found sterigmatocystin alongside DNA from Aspergillus versicolor. Students in classrooms with higher fungal contamination reported more nasal symptoms, eye irritation, and fatigue. While the study could not isolate sterigmatocystin as the sole cause of symptoms, it confirms that indoor mold growth can be a meaningful exposure route.
If you live or work in a building with visible mold, musty odors, or a history of water damage, this test can help you determine whether mold toxins are actually reaching your body, rather than just being present in the environment.
No standardized clinical reference ranges exist for urinary sterigmatocystin. This is a research-stage marker, and published data report detection frequencies and concentration ranges rather than clinical cutpoints. The goal is simple: ideally, this toxin should not be detectable in your urine at all. Any confirmed positive result indicates recent mold exposure.
Because labs use different detection methods with different sensitivity thresholds, a "not detected" result from one lab does not guarantee the same reading at another. Compare your results within the same lab and testing method over time for the most meaningful trend.
A single urine test tells you about a snapshot in time. If your result is positive, the real question is whether that exposure is a one-time event or an ongoing pattern. Retesting after you have made changes, such as removing a suspected food source, remediating mold in your home, or changing your grain and nut suppliers, is the only way to know if those changes actually reduced your exposure.
A reasonable approach: test at baseline, make dietary or environmental changes if positive, and retest in 2 to 3 months. If you are investigating a moldy building, test before and after remediation. Annual testing is sensible for anyone living in a humid climate or eating diets high in grains, nuts, and fermented foods where mold contamination is common.
If sterigmatocystin is detected in your urine, the next step is identifying the source. Consider whether you have been eating foods commonly associated with mold contamination: stored grains, corn products, aged cheeses, coffee, spices, or nuts. Evaluate your home and workplace for signs of water damage or visible mold, especially in older buildings or humid climates.
Order a full mycotoxin panel if you have not already, since sterigmatocystin rarely appears as the only toxin in a contaminated environment. Tests for aflatoxin M1, ochratoxin A, and other common mycotoxins can help you understand the full scope of exposure. If your living or working environment is the suspected source, a professional mold inspection and indoor air quality assessment are practical next steps.
Because no established treatment protocol exists for sterigmatocystin exposure specifically, the strategy is straightforward: find the source, eliminate it, and confirm with follow-up testing that your levels have dropped. If you have symptoms that concern you, such as persistent fatigue, respiratory issues, or unexplained liver enzyme elevations, bring your results to a physician familiar with environmental medicine or mycotoxin exposure.
Evidence-backed interventions that affect your Sterigmatocystin level
Sterigmatocystin is best interpreted alongside these tests.